A detailed history of Seeyond transactions in Dexcom Inc stock. As of the latest transaction made, Seeyond holds 5,607 shares of DXCM stock, worth $628,937. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,607
Previous 6,753 16.97%
Holding current value
$628,937
Previous $543,000 16.76%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $97,387 - $140,579
-1,146 Reduced 16.97%
5,607 $634,000
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $28,020 - $34,564
-367 Reduced 5.15%
6,753 $543,000
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $301,943 - $590,164
4,441 Added 165.77%
7,120 $530,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $44,688 - $61,844
-475 Reduced 15.06%
2,679 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $69,090 - $86,620
-532 Reduced 14.43%
3,154 $1.69 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $53,461 - $71,733
501 Added 15.73%
3,686 $2.02 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $1,133 - $1,511
14 Added 0.44%
3,185 $1.36 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $106,411 - $131,448
-1,255 Reduced 28.36%
3,171 $1.14 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $86,658 - $116,099
1,111 Added 33.51%
4,426 $1.64 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $8,404 - $9,939
88 Added 2.73%
3,315 $1.37 Million
Q2 2020

Aug 13, 2020

SELL
$62.68 - $105.34 $3,134 - $5,267
-50 Reduced 1.53%
3,227 $1.31 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $119,427 - $188,999
2,499 Added 321.21%
3,277 $739,000
Q2 2019

Aug 13, 2019

SELL
$27.84 - $38.92 $107,740 - $150,620
-3,870 Reduced 83.26%
778 $117,000
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $130,469 - $177,460
4,648 New
4,648 $554,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Seeyond Portfolio

Follow Seeyond and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.